‘We need positive destruction’: Yale doctors discuss gender equity on Clubhouse
Inginia Genao, MD, kicked off a recent Clubhouse discussion on gender equity in medicine with a sobering statistic: research shows that nearly 40% of women become part time or leave medicine within six years of completing their residency. The discussion, held May 13, was hosted by the Yale Department of Internal Medicine.
Gill Named PI In NIA Clin-STAR Program
Thomas M. Gill, MD, Humana Foundation Professor of Medicine (Geriatrics) and professor of epidemiology (chronic diseases) and of Investigative Medicine; and director, Yale Program on Aging and Claude D. Pepper Older Americans Independence Center; was named a principal investigator (PI) for Yale School of Medicine (YSM) as part of the new Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) program.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale and Mayo Clinic Awarded FDA Grant to Study Opioid Prescribing and Use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), a joint effort between Yale, Mayo Clinic, and the FDA. The study will be conducted in collaboration with Regional Health of Rapid City, S.D., and University of Alabama at Birmingham (UAB).
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
Most studies misuse data set, researchers find
A team of researchers, including a professor and a postdoctoral researcher at Yale, recently published a paper with troubling findings: The vast majority of a set of studies conducted with data from a widely used public data set are not meeting required methodological standards. According to the study, which was published in the Nov. 28 issue of JAMA, 102 of 120 studies — selected at random and intended as a representative sample of the 1,084 studies published using an open-source database in 2015–16 — did not adhere to one or more required research practices.
Yale launches new program in addiction medicine
The Yale School of Medicine Section of General Internal Medicine has established a new program — the Yale Program in Addiction Medicine. The multi-disciplinary clinical, educational, and research program will further enhance Yale’s portfolio of state-of-the-art addiction research and patient care, while increasing the pipeline of physicians trained in evidence-based strategies to tackle the opioid crisis and other addiction-related health issues.
Yale experts selected to conduct medical device surveillance research
Two projects conducted by Yale School of Medicine faculty have been selected as Demonstration Projects by NEST, the National Evaluation System for Health Technology, which was established by the Medical Device Innovation Consortium and funded by FDA.
Videogame boosts sex health IQ and attitudes in minority teens
A videogame designed by Yale researchers to promote health and reduce risky behavior in teens improves sexual health knowledge and attitudes among minority youth, according to a new study. The findings validate the value of the videogame as a tool to engage and educate teens at risk for HIV and other sexually transmitted infections (STIs), said the researchers.
Pushing Hospitals To Reduce Readmissions Hasn't Increased Deaths
Too often, people return home from the hospital only to find themselves heading back soon after. Sometimes the need arises because, despite the best care, it is difficult to slow the progression of disease. But other times, it's because we in the health care system fail to communicate, coordinate and orchestrate the care that people need to successfully make the transition from hospital to home.Source: NPR Shots
Heart study finds faulty link between biomarkers and clinical outcomes
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to a recent study by Yale School of Medicine researchers in JAMA.
Seeking better health: Yale and New Haven
In the early 1970s, Maria Melendez, recently arrived from Puerto Rico, saw that there were no Spanish-speaking doctors serving her new neighborhood of Fair Haven. With others in the community as well as local groups, she launched a campaign that led first to nursing visits and then to the establishment of the Fair Haven Community Health Center.Source: Yale Medicine
Yale Study: Minority Breast Cancer Patients Less Likely To Have Genetic Test
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.Source: Connecticut Health I-Team
Yale experts question push for ‘abuse-deterrent’ Rx opioids
In response to the rise in opioid overdose deaths nationwide, pharmaceutical companies have developed formulations of prescription opioids designed to prevent tampering or abuse. These “abuse-deterrent” forms, however, are expensive and may not actually have the intended effect, say experts from Yale School of Medicine.
Life expectancy for HIV patients has increased by 10 years in U.S. and Europe
Life expectancy for 20-year-olds initiating treatment for HIV has increased by about a decade in the European Union and North America since the introduction of antiretroviral therapy in the mid-1990s, according to a study co-authored by Yale researcher Dr. Amy Justice and published in The Lancet HIV. The increases are among treated individuals compared with untreated individuals, the global team of researchers said.
Trump wants faster FDA action, but 1 in 3 drugs have safety issues after approval
President Trump wants the Food and Drug Administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of medications that reached the market from 2001 through 2010 had major safety issues years after they became widely available to patients.Source: STAT